What is the recommended dose of Keflex (Cephalexin) for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) Dosing for Cellulitis

For adults with cellulitis, the recommended dose of Keflex (cephalexin) is 500 mg orally four times daily (2 grams total daily dose). 1, 2

Adult Dosing Recommendations

  • For typical non-purulent cellulitis, cephalexin 500 mg four times daily (every 6 hours) is the standard oral regimen 1
  • The usual duration of therapy is 5 days, but treatment should be extended if the infection has not improved within this time period 1
  • For more severe infections, the dose may be increased up to 4 grams daily in divided doses 2
  • Some clinicians use 1000 mg four times daily for more severe cases, which may reduce treatment failure rates compared to standard dosing (12.9% vs 3.2% failure rates in one study) 3

Pediatric Dosing Recommendations

  • For children, the recommended dose is 25-50 mg/kg/day divided into four equal doses 1, 2
  • For skin and skin structure infections in children over 1 year of age, the total daily dose may be divided and administered every 12 hours 2

Clinical Considerations

  • Cephalexin is the oral agent of choice for treating cellulitis caused by methicillin-susceptible strains of Staphylococcus aureus and streptococci 1
  • For patients with non-purulent cellulitis without systemic signs of infection, oral antibiotics like cephalexin are appropriate for outpatient management 1
  • MRSA is an unusual cause of typical cellulitis - β-lactam monotherapy with cephalexin is recommended in the absence of abscess, ulcer, or purulent drainage 1
  • Hospitalization should be considered if there is concern for deeper infection, poor adherence to therapy, immunocompromise, or if outpatient treatment is failing 1

Special Situations

  • For cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, or injection drug use, consider adding coverage for MRSA 1
  • For penicillin-allergic patients (except those with immediate hypersensitivity reactions), cephalexin remains an option 1
  • Elevation of the affected area and treatment of predisposing factors (such as edema, tinea pedis, or venous insufficiency) are important adjunctive measures 1

Common Pitfalls to Avoid

  • Don't extend treatment unnecessarily - 5 days is as effective as 10 days for uncomplicated cellulitis if clinical improvement has occurred 1
  • Don't overlook underlying conditions that may predispose to recurrent cellulitis (tinea pedis, venous insufficiency, lymphedema) 1
  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without risk factors for MRSA 1
  • Don't forget to examine interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 1

Monitoring and Follow-up

  • Patients should show signs of improvement within 48-72 hours of starting appropriate therapy 4
  • Consider adjunctive anti-inflammatory therapy (such as ibuprofen) which may hasten resolution of inflammation 4
  • For non-diabetic adult patients, systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) could be considered as they may attenuate the inflammatory response 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.